ONCO — Oncopeptides AB Share News
0.000.00%
Last trade - 00:00- SEK665.09m
- SEK642.65m
- SEK71.12m
Brief: Oncopeptides Q3 Operating Profit SEK -47.053 Million
Brief: Oncopeptides Issues Warrants To Fulfill Loan Obligations
Brief: Oncopeptides: Rights Issue Oversubscribed To About 157 Percent
Brief: Oncopeptides Q2 Operating Profit SEK -56.234 Million
Brief: Oncopeptides Partners With SD Pharma To Expand Pepasti In Spain
Brief: Oncopeptides Sees Q2 Sales At SEK 19.2 Mln
Brief: Oncopeptides Drug Included In Guidelines For Myeloma
Brief: Oncopeptides Q1 Operating Profit SEK -59.835 Million
Brief: Oncopeptides Gets First Order Of Pepaxti In Italy
Brief: Oncopeptides’ Pepaxti Formally Approved For Full Reimbursement In Italy
Brief: Oncopeptides Gets Reimbursement For Pepaxti In Italy
Brief: Oncopeptides Q3 Operating Profit SEK -61.251 Million
Brief: Oncopeptides Expects To See First Sales From Middle East And North Africa In H2
Brief: Oncopeptides Q2 Operating Profit SEK -73.251 Million
Brief: Oncopeptides Q1 Operating Profit SEK -65.661 Million
Brief: Oncopeptides Presents New Data Highlighting Treatment Benefits Of Pepaxti
Brief: Oncopeptides Says 82% Of Shares Subsribed With Rights In Issue
Brief: Oncopeptides Secures National Reimbursement For Pepaxti In Spain
Brief: Oncopeptides Decides On Rights Issue Of About SEK 314 Mln